Digital Gems

/PRNewswire/ -- Key takeaways With clarity about the upcoming school year and consumer sentiment continuing to rise, back-to-school spending will be at its...

In a new annual report, ECLAC estimates that the total number of poor people rose to 209 million by the end of 2020, which is 22 million more people than in the previous year. In addition, it calls for creating a new welfare state.

The SARS-CoV-2 B.1.617 lineage was identified in October 2020 in India1–5. It has since then become dominant in some indian regions and UK and further spread to many countries6. The lineage includes three main subtypes (B1.617.1, B.1.617.2 and B.1.617.3), harbouring diverse Spike mutations in the N-terminal domain (NTD) and the receptor binding domain (RBD) which may increase their immune evasion potential. B.1.617.2, also termed variant Delta, is believed to spread faster than other variants. Here, we isolated an infectious Delta strain from a traveller returning from India. We examined its sensitivity to monoclonal antibodies (mAbs) and to antibodies present in sera from COVID-19 convalescent individuals or vaccine recipients, in comparison to other viral strains. Variant Delta was resistant to neutralization by some anti-NTD and anti-RBD mAbs including Bamlanivimab, which were impaired in binding to the Spike. Sera from convalescent patients collected up to 12 months post symptoms were 4 fold less potent against variant Delta, relative to variant Alpha (B.1.1.7). Sera from individuals having received one dose of Pfizer or AstraZeneca vaccines barely inhibited variant Delta. Administration of two doses generated a neutralizing response in 95% of individuals, with titers 3 to 5 fold lower against Delta than Alpha. Thus, variant Delta spread is associated with an escape to antibodies targeting non-RBD and RBD Spike epitopes.

One dose of vaccine is not enough to protect against the Delta and Beta variants, new research suggests, and even people who have had Covid-19 should be immunized.

Lenders extended a record number of auto loans and leases in March and issued more general-purpose credit cards than any other March on record.

The agency faced criticism for approving Aduhelm for all Alzheimer’s patients. The new label recommends that the drug be given only to patients with mild symptoms.

Hear from British Vogue's Editor in Chief Edward Enninful on how we can build a fairer post-pandemic world through diverse perspectives and a focus on empathy.

Google's Official Digital Marketing Publication. Discover how to run more intentionally inclusive meetings with these practices and tips.

This cohort study examines the duration and variation of recovery among COVID-19–positive verses COVID-19–negative individuals.

Israel reported that the Pfizer vaccine was 64 percent effective against the Delta variant. Other studies suggest a higher rate.

Recently, I had gone through a bout of stress - I had taken on too much work, injured my back, and was generally feeling out of touch with myself. I’ll admit that there were times when I was preaching the importance of self-care to a crowd...in the middle of a 60-hour work week. And the clumps

I have the little-known gynaecological condition, and no one can help me.

Far from dissipating over the last decade, misogyny in the ad industry has simply mutated into something insidious, invisible, lurking in the shadows. It’s time to fire up the floodlights.